Hypoallergenic derivatives of the major birch pollen allergen Bet v 1 obtained by rational sequence reassembly

Journal of Allergy and Clinical Immunology

Volumn 126, Issue 5, 2010, Pages

  Campana, Raffaela ^a   Vrtala, Susanne ^a   Maderegger, Bernhard ^b   Jertschin, Peter ^b   Stegfellner, Gottfried ^b   Swoboda, Ines ^a   Focke Tejkl, Margarete ^a   Blatt, Katharina ^a   Gieras, Anna ^a   Zafred, Domen ^c   Neubauer, Angela ^b   Valent, Peter ^a   Keller, Walter ^c   Spitzauer, Susanne ^a   Valenta, Rudolf ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b BIOMAY AG   (Austria)

^c UNIVERSITY OF GRAZ   (Austria)

Author keywords

Birch pollen allergy; Immunotherapy; RBet v 1; Recombinant hypoallergenic derivative molecules

Indexed keywords

POLLEN ANTIGEN; RECOMBINANT BET V 1 MOSAIC PROTEIN; RECOMBINANT BET V 1 PROTEIN; RECOMBINANT BET V 1 RS1 PROTEIN; RECOMBINANT BET V 1 RS2 PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; BASOPHIL; BIRCH; CODON; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOTHERAPY; NONHUMAN; POLLEN ALLERGY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; T LYMPHOCYTE;

EID: 78049478718     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.05.023     Document Type: Article

References (39)

1. N. Mothes, F. Horak, and R. Valenta Transition from a botanical to a molecular classification in tree pollen allergy: Implications for diagnosis and therapy Int Arch Allergy Immunol 135 2004 357 373
2. H. Breiteneder, K. Pettenburger, A. Bito, R. Valenta, D. Kraft, and H. Rulpold The gene coding for the major birch pollen allergen Bet v I, is highly homologous to a pea disease resistance response gene EMBO J 8 1989 1935 1938
3. V. Niederberger, G. Pauli, H. Grönlund, R. Fröschl, H. Rumpold, and D. Kraft Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen: a quantitative IgE inhibition study with sera from different populations J Allergy Clin Immunol 102 1998 579 591
4. L. Kazemi-Shirazi, G. Pauli, A. Purohit, S. Spitzauer, R. Fröschl, and K. Hoffmann-Sommergruber Quantitative IgE inhibition experiments with purified recombinant allergens indicate pollen-derived allergens as the sensitizing agents responsible for many forms of plant food allergy J Allergy Clin Immunol 105 2000 116 125
5. G. Pauli, J.P. Oster, P. Deviller, S. Heiss, J.C. Bessot, and M. Susani Skin testing with recombinant allergens rBet v 1 and birch profillin, rBet v 2: diagnostic value for birch pollen and associated allergies J Allergy Clin Immunol 97 1996 1100 1109
6. R. Movérare, K. Westritschnig, M. Svensson, B. Hayek, M. Bende, and G. Pauli Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: an imprint of local sensitization Int Arch Allergy Immunol 128 2002 325 335
7. G. Pauli, T.H. Larsen, S. Rak, F. Horak, E. Patorello, and R. Valenta Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis J Allergy Clin Immunol 122 2008 951 960
8. B. Linhart, and R. Valenta Molecular design of allergy vaccines Curr Opin Immunol 17 2005 646 655
9. S. Vrtala, K. Hirtenlehner, L. Vangelista, A. Pastore, H.G. Eichler, and W.R. Sperr Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy J Clin Invest 99 1997 1673 1681
10. S. Vrtala, K. Hirtenlehner, M. Susani, M. Akdis, F. Kussebi, and C.A. Akdis Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen, Bet v 1 FASEB J 15 2001 2045 2057
11. V. Niederberger, F. Horak, S. Vrtala, S. Spitzauer, M.T. Krauth, and P. Valent Vaccination with genetically engineered allergens prevents progression of allergy disease Proc Natl Acad Sci U S A 101 2004 14677 14682
12. A. Purohit, V. Niederberger, M. Kronqvist, F. Horak, R. Grönneberg, and R. Suck Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives Clin Exp Allergy 38 2008 1514 1525
13. J. Reisinger, F. Horak, G. Pauli, M. van Hage, O. Crommwell, and F. König Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity J Allergy Clin Immunol 116 2005 347 354
14. H. Kahlert, R. Suck, B. Weber, A. Nandy, M. Wald, and W. Keller Characterization of hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy Int Arch Allergy Immunol 145 2008 193 206
15. L. Klimek, C. Bachert, C. Doerner, H. Meyer, and A. Narkus Specific immunotherapy with recombinant birch pollen allergen rBet v. 1-FV is clinically efficacious [abstract] Allergy Clin Immunol Int suppl 1 2005 15
16. Rak S. Clinical results with an hypoallergenic recombinant birch pollen allergen derivative [abstract]. Congress of European Academy of Allergy and Clinical Immunology 2009.
17. K. Hoffmann-Sommergruber, M. Susani, F. Ferreira, P. Jertschin, H. Ahorn, and R. Steiner High-level expression and purification of the major birch pollen allergen, Bet v 1 Protein Expr Purif 9 1997 33 39
18. S. Laffer, L. Vangelista, P. Steinberger, D. Kraft, A. Pastore, and R. Valenta Molecular characterization of Bip 1, a monoclonal antibody that modulates IgE binding to birch pollen allergen, Bet v 1 J Immunol 157 1996 4953 4962
19. P. Wiedemann, K. Giehl, S.C. Almo, A.A. Fedorov, M. Girvin, and P. Steinberger Molecular and structural analysis of a continuous birch profilin epitope defined by a monoclonal antibody J Biol Chem 271 1996 29915 29921
20. S.P. Fling, and D.S. Gregerson Peptide and protein molecular weight determination by electrophoresis using a high-molarity tris buffer system without urea Anal Biochem 155 1986 83 88
21. H. Towbin, T. Staehelin, and J. Gordon Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications Proc Natl Acad Sci USA 76 1979 4350 4354
22. S. Vrtala, C.A. Akdis, F. Budak, M. Akdis, K. Blaser, and D. Kraft T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies J Immunol 165 2000 6653 6659
23. G. Pauli, A. Purohit, J.P. Oster, F. De Blay, S. Vrtala, and V. Niederberger Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wild-type by skin prick and intradermal testing: results obtained in a French population Clin Exp Allergy 30 2000 1076 1084
24. van Hage-Hamsten, M. Kronqvist, O. Zetterström, E. Johansson, V. Niederberger, and S. Vrtala Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season J Allergy Clin Immunol 104 1999 969 977
25. A. Nopp, G. Halldén, J. Lundahl, E. Johansson, S. Vrtala, and R. Valenta Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1 and to recombinant Bet v 1 wild type in skin chamber fluids collected from birch pollen-allergic patients J Allergy Clin Immunol 106 2000 101 109
26. M. Focke, B. Linhart, A. Hartl, U. Wiedermann, W.R. Sperr, and P. Valent Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination Clin Exp Allergy 34 2004 1525 1533
27. K. Westrischnig, B. Linhart, M. Focke-Tejkl, T. Pavkov, W. Keller, and T. Ball A hypoallergenic vaccine obtained by tail-to head restructuring of timothy grass pollen profilin, Phl p 12, for the treatment of cross-sensitization to profilin J Immunol 179 2007 7624 7634
28. 142-153 is the dominant T-cell epitope of the major birch pollen allergen and important for cross-reactivity with Bet v 1-related food allergens J Allergy Clin Immunol 116 2005 213 219
29. N. Mothes, M. Heinzkill, K.J. Drachenberg, W.R. Sperr, M.T. Krauth, and Y. Majlesi Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies Clin Exp Allergy 33 2003 1198 1208
30. M. Wallner, A. Stöcklinger, T. Thalhamer, B. Bohle, L. Vogel, and P. Briza Allergy multivaccines created by DNA shuffling of tree pollen allergens J Allergy Clin Immunol 120 2007 374 380
31. N. Mothes-Luksch, S. Stumvoll, B. Linhart, M. Focke, M.T. Krauth, and A. Hauswirth Disruption of allergenic activity of the major grass pollen allergen Phl p 2 by reassembly as a mosaic protein J Immunol 181 2008 4864 4873
32. T. Ball, B. Linhart, K. Sonneck, K. Blatt, H. Herrmann, and P. Valent Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination Allergy 64 2009 569 580
33. R. Valenta The future of antigen-specific immunotherapy of allergy Nat Rev Immunol 2 2002 446 453
34. U. Wiedermann Prophylaxis and therapy of allergy by mucosal tolerance induction with recombinant allergens or allergen constructs Curr Drug Targets Inflamm Allergy 4 2005 577 583
35. R. Weiss, S. Scheiblhofer, and J. Thalhamer DNA vaccines for allergy treatment Methods Mol Med 127 2006 253 267
36. U. Barany, B. Linhart, N. Pilat, M. Gattringer, J. Bagley, and F. Muehlbacher Tolerization of a type I allergic immune response through transplantation of genetically modified hematopoietic stem cells J Immunol 180 2008 8168 8175
37. S.P. Fling, and D.S. Gregerson Peptide and protein molecular weight determination by electrophoresis using a high-molarity tris buffer system without urea Anal Biochem 155 1986 83 88
38. L. Whitmore, and B.A. Wallace DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data Nucleic Acids Res 32 2004 668 673
39. A.W. Hauswirth, S. Natter, M. Ghannadan, Y. Majlesi, G.H. Schernthaner, and W.R. Sperr Recombinant allergens promote expression of CD203c on basophils in sensitized individuals J Allergy Clin Immunol 110 2002 102 109